Serotonin Receptor Antagonists

    Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review

    Tricco AC, Soobiah C, Hui W, Antony J, Struchkov V, Hutton B, Hemmelgarn B, Moher D, Straus SE. Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review. BMC Pharmacol Toxicol. 2015;16:1. DOI: 10.1186/2050-6511-16-1

     

    Altmetric:

    Impact:

    • Provided Health Canada with evidence on the safety of these agents for their decision-making
    Funding:

    Canadian Institutes of Health Research (CIHR)/Drug Safety and Effectiveness Network (DSEN)


    Comparative safety and effectiveness of serotonin receptor antagonists in patients undergoing chemotherapy: a systematic review and network meta-analysis


    Tricco AC, Blondal E, Veroniki AA, Soobiah C, Vafaei A, Ivory J, Strifler L, Cardoso R, Reynen E, Nincic V. Comparative safety and effectiveness of serotonin receptor antagonists in patients undergoing chemotherapy: a systematic review and network meta-analysis. BMC Medicine. 2016;14(1):216. DOI: 10.1186/s12916-016-0761-9

     

    Altmetric:

    Impact:

    • Provided Health Canada with evidence on the safety and effectiveness of these agents for their decision-making

    Canadian Institutes of Health Research (CIHR)/ Drug Safety and Effectiveness Network (DSEN)


    Comparative efficacy of serotonin (5-HT3) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis

    Tricco AC, Soobiah C, Blondal E, Veroniki AA, Khan PA, Vafaei A, Ivory J, Strifler L, Ashoor H, MacDonald H, Reynen E, Robson R, Ho J, Ng C, Antony J, Mrklas K, Hutton B, Hemmelgarn BR, Moher D, Straus SE. Comparative efficacy of serotonin (5-HT3) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis. BMC Med. 2015;13:136. DOI: 10.1186/s12916-015-0371-y

     

    Altmetric:

    Impact:

    • Provided Health Canada with evidence on the efficacy of these agents for their decision-making

    Canadian Institutes of Health Research (CIHR)/ Drug Safety and Effectiveness Network (DSEN)


    Comparative safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis

    Tricco AC, Soobiah C, Blondal E, Veroniki AA, Khan PA, Vafaei A, Ivory J, Strifler L, Ashoor H, MacDonald H, Reynen E, Robson R, Ho J, Ng C, Antony J, Mrklas K, Hutton B, Hemmelgarn BR, Moher D, Straus SE. Comparative safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis. BMC Med. 2015;13:142. DOI: 10.1186/s12916-015-0379-3

     

    Altmetric:

    Impact:

    • Provided Health Canada with evidence on the efficacy of these agents for their decision-making

    Canadian Institutes of Health Research (CIHR)/ Drug Safety and Effectiveness Network (DSEN)

    Category :

    Date : 24 Aug 2017